Coremed Technology Research Abstracts For more information about Coremed please contact info@coremedusa.com   Coremed Research Abstracts     2005 American Diabetes Association 65th Scientific Sessions      Glucose Responses of Pulmonary-delivered Alveair Formulated with Unmodified Chinese-made Analog Insulin in Normal Rats Glucodynamic Profile and Glucose Dose-Responses of Alveair (Pulmonary-delivered) in Comparison to Aspart (Subcutaneous Injection) in Normal Rats with Food Intake Improved Efficacy of Intesulin (Oral Insulin) Formulated with Unmodified Regular Insulin in Normal Rats Insulin Bioavailability and pK Estimates of Intravenous Alveair Formulation Comparison of Insulin Bioavailability and pK Estimates of Alveair Formulation Administered by Pulmonary and Intravenous Routes Insulin Bioavailability and pK Estimates of Alveair Formulated with Unmodified Regular Insulin Unmodified Inhalable Regular Insulin (Alveair-R) Has Same Glucodynamic Profile and Effectiveness as Compared to Inhalable Analog Monomer insulins Intesulin (Oral Insulin) Hepatic Vein Cmax insulin levels in Streptozocin-induced Diabetic Rats by Gavage Delivery     2004 American Diabetes Association 64th Scientific Sessions      Alveair™, A New Pulmonary Insulin - Its Glucose Responses Compared to Aspar Insulin Intravenous Injection in Normal Rats and Its Insulin Profile in Guinea Pigs Insulin Pharmacokinetic Estimates of Alveair™ - A New Pulmonary Insulin Formulation Dose-Responseness of Alveair™ Insulin in Normal Rats - A New Pulmonary Insulin Formulation. Alveair™, A New Pulmonary Insulin - Its Glucodynamic Profile Comparing to Aspar Insulin Subcutaneous Injection in Normal Rats Alveair™, A New Pulmonary Insulin - Its First Human Trial and The Pre-clinical Animal Data Correlation Effects of Immediate Food Intake Following Gavage Delivery of Intesulin (oral insulin) in Diabetic Rats Effects of Food Intake Thirty Minutes Following Gavage Delivery of Intesulin (oral insulin) in Diabetic Rats Effects of Immediate Food Intake Following Orally-delivered Intesulin by Gavage method and Its Comparison to Aspar Subcutaneous Injection in Diabetic Rats Glucose Responses to Oral Delivery of Intesulin™ by Gavage Method in Guinea Pigs     2003 American Diabetes Association 63rd Scientific Sessions      Identical glycodynamic profile of an intranasally delivered insulin formulation (Nasulin) in comparison to subcutaneous Aspar injection in non-diabetic rats Bi-phasic Transmucosal Insulin Release Mechanism: Delivered Intranasally (Nasulin) in the Control of Pre-meal and Post-meal Glucose Levels in Non-diabetic Rats Treatment of Severe Diabetic Ketoacidosis in Streptozocin-induced Diabetic Rats with a Low Dose Oral Insulin (Musulin) The Effects of Low Dose Oral Insulin (Musulin) in the Control of Hyperglycemia in Streptozocin-induced Diabetic Rats A long-acting transmucosal insulin formuation delivered per-orally (Musulin) as tested in non-diabetic rats Control of pre-meal and post-meal glucose levels with per-orally delivered insulin (Musulin) in non-diabetic rats     2003 Endocrine Society 85th Annual Meeting       Significant Hypoglycemic Effect of a Perorally-delivered Insulin in the Treatment of Streptozocin-induced Diabetic Rats Signifcant Enhancement of Triglyceride-lowering Effect by Intraduodenum-delivered Oral Insulin, Simavastatin and Pravastatin, formulated with Coremed s drug delivery system, in comparison to Atrovastatin in rats Glucose Responses to Food Intake in Non-diabetic Rats Treated with Per-orally Delivered Insuln (Musulin)     2002 Amercan Diabetes Association 62nd Scientific Sessions     Significant Hypoglycemic Effect of a Perorally-delivered Insulin in the Treatment of Streptozocin-induced Diabetic Rats Marked Triglyceride-lowering Effect of Intraduodenum-delivered Oral Insulin, Simavastatin and Pravastatin Formulated with Coremed's Drug Delivery System     2001 American Diabetes Association 61st Scientific Sessions     A New Transmucosal Insulin Formulation -Findings of Superior and Better Insulin Absorption in Diabetic Rats by 686% in Comparison to Non-diabetic controls A New Transmucosal Insulin Formulation - Findings of Its Insulin Pharmacokinetics Superiority Which Surpass Results in Subcutaneous Insulin Injection in Non-diabetic Rats A New Transdermal Insulin Formulation - Results of Insulin Pharmacokinetics and Hypoglycemic Efficacy in Comparison to Azone and Subcutaneous Insulin Inejctions in Non-diabetic Rats A New Oral Insulin Formulation - Results of Long-term Daily Glucose Control of Diabetic Rats     2001 Endocrine Society 83rd Annual Meeting       A new intestinal transmucosal insulin formulation (Intesulin) - its glucose responses and insulin pharmacokinetics in diabetic rats and in comparison to subcutaneous insulin injection. A new intragastric transmucosal insulin (Gastrisulin) - its glucose responses in non-diabetic rats and in comparison to its Azone(Laurocapram) formulation. A new oral insulin formulation (Musulin) - its glucose responses and insulin pharmacokinetics in non-diabetic rats and in comparison to subcutaneous insulin injection.
Home  |  News  |  Products  |  Technology  |  Investors  |  About Us  ©2004 Coremed, Inc.